Spyre Therapeutics, Inc. (SYRE)
NASDAQ·Healthcare·Biotechnology
$104.46
+10.14%
Mkt Cap $8.50B
Analyst Ratings
Buy
19
Hold
0
Sell
0
Price Target (22 analysts)
$97.64
Range $49.00 – $135.00
Implied Upside
-6.5%
Consensus $97.64 vs current $104.46
NASDAQ·Healthcare·Biotechnology
$104.46
+10.14%
Mkt Cap $8.50B
Buy
19
Hold
0
Sell
0
Price Target (22 analysts)
$97.64
Range $49.00 – $135.00
-6.5%
Consensus $97.64 vs current $104.46